task
0 (0 Likes / 0 Dislikes)
Hello people, um
I want to talk to you about Covid-19 vaccine
Ok, the one developed by University of Oxford together with Astrazeneca
Just a company, alright?
Resently they published the results for the, so the overall efficacy of the vaccine
Uh, the number was 70%
Now compared to the other two
With numbers in the region of 90-95%
This look bad
However
It turn out they made a mistake
With about three thousand people volunteers
And, because they gave to this people a lower dose, the gene of the vaccine
So basically, they gave the same amount of liquid
But there was less amount of vaccine in the liquid
It was diluted
So
This was a mistake
But it turns out that when you... do that
In the first dose, and then you...
And then you give the full amount in the second
It looks like
The overall efficacy
Rises from 70 to round 90 percent
Now, taking into account
That this vaccine is cheaper than the other two
Within the region of 2-3 euros round... 20 or whatever
And
That it can be storaged in fridges
Alright
At fridge temperature
Around eight degrees positive
Rather minus twenty, minus eighty
So of course this...
That... All of this two characteristics
Make this vaccine much better
So, the only problem would be the lower efficacy
But
If it turns out that the overall efficacy is actually in the region of 90%
Then that's really good
So it looks like they are going to do new trials now
But then of course
Some people are saying "uhm"
If they are making new ones, it's because they didn't do it alright the first time, and so on
So it´s tricky